top of page

Search Results

541 items found for "Jespers W"

  • VAMP2: a crucial player in the delivery of MOR to the synapse

    Transporting Protein-coupled receptors (GPCRs) to the synapse, where they are involved in neurotransmission vesicle-associated-membrane-protein-2-is-a-cargo-selective-v-snare-for-a-subset-of-gpcrs #GPCR #DrGPCR#Ecosystem Crilly, S.E., W. Weinberg, and M.A. Puthenveedu. 2021. Wang, F., X. Chen, X. Zhang, and L. Ma. 2008. Wickner, W., and R. Schekman. 2008. Membrane fusion. Nat. Struct. Mol. Biol. 15:658–664.

  • Newly launched antibody libraries put hard-to-drug targets within reach

    November 2021 "Target class-specific libraries mean you need to screen less to identify high-quality antibodies. Aaron Sato, Chief Scientific Officer at Twist Bioscience, elaborates. Antibody developers are increasingly utilising antibody libraries to derive high-quality, drug-like biologics. However, only a few general-purpose libraries have been commercially available for drug discovery. As a result, most approved library-derived antibodies originate from just three libraries. The drugs also target relatively low-hanging fruit: like cytokines or tyrosine kinase receptors. To target hard-to-drug targets like G protein-coupled receptors (GPCRs), more libraries, including better and more targeted libraries, are needed." Read more at the source #DrGPCR #GPCR #IndustryNews

  • Nanobodies: New Dimensions in GPCR Signaling Research

    Nbs typically consist of a single polypeptide chain which contains the antigen-binding site and the effector H., Pautsch, A., Steyaert, J., Weis, W. I., & Kobilka, B. K. (2011). C., Gmeiner, P., Steyaert, J., Weis, W. I., Garcia, K. C., Wess, J., & Kobilka, B. K. (2013). N., Angelini, A., Waghray, D., Dror, R. O., Ploegh, H. L., & Garcia, K. C. (2015). D., Tworak, A., Watanabe, K., Pardon, E., Steyaert, J., Kandori, H., Katayama, K., Kiser, P.

  • G-protein-coupled receptors as therapeutic targets for glioblastoma

    impacted quality of life during treatment coupled with brain tumour recurrence; thus, new treatments are desperately In this review, we focus on recent advances in G-protein-coupled receptor (GPCR) targets. date, the most promising targets are the chemokine, cannabinoid, and dopamine receptors, but future work

  • Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...

    receptor activation, make this receptor an intriguing target for treating schizophrenia, a disease where novel interventions that move beyond dopamine receptor antagonists are desperately needed. While more work is needed to further elucidate the translational value of selectively targeting CB2 receptors below could suggest that CB2 receptors are anatomically located in schizophrenia-relevant circuits, where

  • Do You Believe AI Could Accelerate Drug Discovery?

    The highest affinity compounds (15 to 24 nM) were identified from AF2 docking. One significant concern is the reliance on data quality and quantity, where inaccuracies or biases in Moreover, advanced AI models like AlphaFold3, which can predict complex protein-molecule interactions design is set to spark innovation in automated screening and large-scale data analysis, paving the way Nature 630, 493–500 (2024). https://doi.org/10.1038/s41586-024-07487-w

  • Ode to GPCRs

    Earl W. Earl W. Earl W. Sir James W. Sir James W.

  • Identification of hub genes in the subacute spinal cord injury in rats

    Subacute SCI is mainly characterized by neuronal apoptosis, axonal demyelination, Wallerian degeneration Methods The gene expression profiles of GSE20907, GSE45006, and GSE45550 were downloaded from the GEO The models of the three gene expression profiles were all for SCI to the thoracic segment of the rat. The differentially expressed genes (DEGs) and weighted correlation network analysis (WGCNA) were performed using R software, and functional enrichment analysis and protein–protein interaction (PPI) network were

  • G.CLIPS biotech is 2 years old this month!

    When I came this morning to work this is how I found my desk. So very grateful to the great hard working team we have and all the great achievements we have done together Looking forward for more 🎊 #team #grateful #biotech #work #birthdaycelebration" Read more at the source

  • Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling

    Surprisingly, this interaction did not result in G12 activation, even in the presence of GTP, which is In 2017, Gupte et al. introduced GPCR priming, which posits that non-cognate G proteins can enhance the to show that Gq proteins could bolster Gs dependent-β2-adrenergic receptor-mediated cAMP signalling, while in GPCR priming is attributed to the formation of temporal non-cognate-GPCR conformational states, which Stallaert, W., et al., Purinergic Receptor Transactivation by the β(2)-Adrenergic Receptor Increases

  • Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling

    While GPCRs can exist as monomers, some types, like class C GPCRs, are obligate dimers, either as homodimers These dimeric forms, which can either be transient or stable, are believed to influence the function While class B1 GPCRs were initially thought to function primarily as monomers, mounting evidence suggests Guo, W., et al., Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface Wootten, D., et al., Allostery and Biased Agonism at Class B G Protein-Coupled Receptors.  

  • Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...

    Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall webworm Hyphantria the leucine-rich repeat-containing (LGR2) gene in Hyphantria cunea (HLGR2) was performed to examine whether Results: The complementary DNA (cDNA) sequence and deduced amino acids of HLGR2 were obtained and analyzed After RNAi of HLGR2, distinct phenotypes were observed when HLGR2 expression was suppressed, indicating Furthermore, we identified eight genes that are regulated by HLGR2.

  • From DNA day to GPCR genomics

    What does DNA Day have to do with GPCRs? happen when a receptor is activated. were predicted to have a functional effect4. GPCR world. W., & Skiniotis, G. (2023).

  • Harnessing Deep Mutational Scanning for Enhanced Drug Discovery

    scanning (DMS) is a powerful method for studying the functional consequences of various genetic variants within protein regions are crucial for binding the drug and which mutations affect its potency and efficacy to a drug and which might suffer adverse effects. This would help bridge the gap between in-vitro findings and clinical outcomes. G., Coyote-Maestas, W., & Aashish Manglik. (2024).

  • Odorant receptors – a bit of smell for drug discovery

    ORs are highly expressed by olfactory sensory neurons of the nose where they are activated by different odorant molecules which initiate a neuronal response that drives odorant discrimination and perception also expressed in non-olfactory tissues including the testis, lung, intestine, skin, heart, and blood, where For example, OR4M1 was proposed to interfere with aberrant tau hyperphosphorylation (Zhao W. et. al 2013 these receptors would be of great help to aid drug discovery.

  • Decoding β-Arrestins: from Structure to function

    cavity (Kang, Y. et al. 2015, Chen, Q. et al. 2021), that allow interaction with trimeric G proteins, which While some receptors selectively activate specific G protein families, others are more versatile, yielding M. et al. 1999), while dual knockout is lethal (Schmid, C. L., & Bohn, L. M. 2009). their imbalance is linked to pathological conditions, including cancer (Gros, R. et al. 2000, Sun, W. Pinpointing signaling pathways governed by β-arrestins, which exhibit increased or reduced activity within

  • 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024

    As the year wraps up, we're thrilled to present the final edition of the GPCR Weekly Newsletter for 2024 As researchers, we all understand the importance of data in driving meaningful discoveries  and advancing We’d love to hear your thoughts on our website and its features  so that we can continue to support your work and foster collaborations in the GPCR field.   GPCR Team This Week’s Highlights: Congratulations to Andrew Tobin for an incredible week filled with

  • GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024

    We've got an early holiday treat for you: The University CheatSheet ! We are thrilled to announce that we've been working tirelessly to bring you a simple, beautiful, and Dive into a world of knowledge where you can search by topics and events . We are bursting with pride in sharing it with you, and we sincerely want to thank you for your support We are ecstatic to create a space where the GPCR Community can thrive with information and INSPIRATION

  • Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024

    We're zooming back to the future of GPCR discoveries. Buckle up as we time-hop through this week's GPCR escapade! This Week’s Highlights: G protein-coupled receptor (GPCR) pharmacogenomics Miles D Thompson , David Calcineurin-fusion facilitates cryo-EM structure determination of a Family A GPCR Jun Xu , Geng Chen , Haoqing Wang Please don't say we didn't give you a heads-up!

  • 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024

    Explore the newest breakthroughs and thrilling research findings in this week's update! This Week’s Highlights: Celebrating Excellence:   Patrick Sexton  and Arthur Christopoulos  Named Among High-affinity agonists reveal recognition motifs for the MRGPRD GPCR Chunyu Wang ,  Yongfeng Liu ,  Marion 🕵️‍♂️We'll soon be unveiling our University CheatSheet! Major Announcement! Jude Children's Research Hospital Welcomes Dr.

  • Reflections on My PhD Journey: Lessons Learned

    Here's a glimpse into my PhD story and what I’ve learned along the way. However, with multiple great options, choosing the right lab wasn't easy. results, and outline my goals for the next week. It’s easy to focus solely on generating data when experiments are working smoothly, but neglecting to analyze that data in real-time can create a backlog of work later.

  • Profiling Immune Cell and Platelet Transcriptomes

    G protein-coupled receptors (GPCRs) are integral to cellular signaling, influencing a wide array of physiological The study reports that human white blood cells express an average of 160 GPCR mRNAs, ranging from 123 to 206, while platelets exhibit a distinct profile with 69 GPCR mRNAs. This analysis utilized a semi-quantitative multiplex PCR method, which allowed for the detection of both et al., which reported 165 GPCR mRNAs in alveolar macrophages.

  • Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR

    To achieve this, the work of Heydenreich et al. (2023) will be analysed to demonstrate how mutagenesis residues , which affect nearby regions but do not make active state-specific contacts. For example, orthosteric drug design —in which drugs bind to the receptor’s primary active site—can now Interestingly, only 10 out of 82 important residues are within the ligand-binding pocket, resulting in In the next article, we will explore this emerging field in greater detail.

  • AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof

    was the most common method for predicting G protein-coupled receptor (GPCR) structures, especially when experimental data were limited. that eliminates the need for structural templates, allowing it to predict structures for GPCRs that were The results were striking: AlphaFold2 outperformed homology models, achieving a 60% hit rate for compounds While AlphaFold2’s ability to predict static structures was groundbreaking, however, GPCRs are highly

  • 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024

    Instead of just staying up to date, dive in, broaden your knowledge, and pave the way in the fantastic world of the GPCR field! No worries – you can sign up for a 5-day FREE trial! Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing Our goal is to ensure that education is within reach for everyone!

  • Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes

    Biased agonism is a phenomenon where different ligands acting on the same receptor trigger distinct signaling It is primarily coupled to the Gs protein, which leads to the production of cyclic AMP (cAMP). For instance, the interaction of GLP-1 with ECL3, which leads to a tight conformation of the receptor's Willard, F.S., et al., Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.   JAMA Internal Medicine, 2024. 184 (9): p. 1056-1064. 11. https://www.evaluate.com/thought-leadership/

  • Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024

    This Week’s Highlights: Celebrating Excellence: Wessel A. C. No worries – you can sign up for a 5-day FREE trial! Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing Our goal is to ensure that education is within reach for everyone! Secure your spot today and dive into the evolving world of GPCRs!

  • Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024

    Weekly Highlights: Congrats to: Daniel Matúš , Simone Prömel , et al., for their work on The N terminus-only No problem – we offer a 5-day FREE trial! Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing Our goal is to ensure that education is within reach for everyone! Secure your spot today and dive into the evolving world of GPCRs!

bottom of page